Canada Pharmaceuticals and Healthcare Report Q3 2014

News provided by

Jun 09, 2014, 08:33 ET

LONDON, June 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Canada Pharmaceuticals and Healthcare Report Q3 2014

http://www.reportbuyer.com/pharma_healthcare/therapeutic/canada_pharmaceuticals_healthcare_report_q3_2013_1.html

Includes 3 FREE quarterly updates
BMI View: The Canadian pharmaceutical and healthcare market will become increasingly attractive to pharmaceutical companies over the next few years as economic growth in the country gradually accelerates. The hospitable business environment, improving healthcare coverage and broader drug
reimbursement lists will continue to provide revenue-generating opportunities for drugmakers.

Headline Expenditure Projections
- Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.9bn (USD22.5bn) in 2014; +0.8% in local currency terms and -9.7% in US dollar terms. Forecast changed from Q214 due to changes to macroeconomic data.
- Healthcare: CAD204.5bn (USD198.6bn) in 2013 to CAD212.1bn (USD184.5bn) in 2014; +3.7% in local currency terms and -7.1% in US dollar terms. Forecast up from Q214 due to changes to macroeconomic data.
BMI Industry View . 7
SWOT .. 9
Political 11
Economic ... 12
Industry Forecast 13
Pharmaceutical Market Forecast .. 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2010-2018) . . 14
Healthcare Market Forecast ... 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018) . . 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018) . . . 17
Prescription Drug Market Forecast ... 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018) . . 19
Patented Drug Market Forecast ... 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018) . . 22
Generic Drug Market Forecast .... 22
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018) . 25
OTC Medicine Market Forecast ... 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2010-2018) . . . 27
Pharmaceutical Trade Forecast ... 28
Table: Pharmaceutical Trade Data And Forecasts (Canada 2012-2018) . 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Canada 2012-2018) . 29
Other Healthcare Data 29
Table: Health Expenditure By Sector And Type, 2009 (CADmn) . . 30
Table: Pharmacists By Type, Province And Territory, 2011 . . 31
Table: Active Physicians, 2005-2009 . . 32
Key Risks To BMI's Forecast Scenario 33
Macroeconomic Forecasts 34
Economic Analysis . 34
Table: Canada - Economic Activity . 36
Industry Risk Reward Ratings 42
Americas Risk/Reward Ratings 42
Canada Risk/Reward Ratings .. 48
Rewards ... 48
Risks ... 49
Market Overview . 50
Industry Trends And Developments 51
Epidemiology . 51
Non-Communicable Diseases 52
Healthcare Sector 54
Table: Sustainability Of Public Health Expenditure And Pharmaceutical Approval Indicators . . 55
Research & Development 58
Biotechnology 60
BioSimilar Medicines . 62
Personalised Medicine .... 62
Regulatory Development ... 64
Pharmacovigilance .... 65
Intellectual Property Regime . 68
Pricing Regime .... 71
Reimbursement Regime ... 72
Recent Developments . 75
Competitive Landscape 79
Pharmaceutical Industry . 79
Table: Top 20 Pharmaceutical Companies According To Market Capitalisation On The Canadian Stock Exchange . . . 79
Pharmaceutical Re-import Policy 80
Recent Pharmaceutical Company Developments 82
Pharmaceutical Retail 82
Company Profile .. 85
Apotex .. 85
Valeant . 88
Pfizer ... 95
GlaxoSmithKline ... 99
Sanofi . 103
Merck & Co ... 106
Novartis ... 109
Demographic Forecast .... 112
Table: Canada's Population By Age Group, 1990-2020 ('000) . . . 113
Table: Canada's Population By Age Group, 1990-2020 (% of total) . 114
Table: Canada's Key Population Ratios, 1990-2020 . 115
Table: Canada's Rural And Urban Population, 1990-2020 . . . 115
Glossary ... 116
Methodology . 118
Pharmaceutical Expenditure Forecast Model .. 118
Healthcare Expenditure Forecast Model .... 118
Notes On Methodology .. 119
Risk/Reward Ratings Methodology . 120
Ratings Overview .... 121
Table: Pharmaceutical Risk/Reward Ratings Indicators . . 121
Indicator Weightings .... 122